News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
156 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (26877)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
1 (189)
2 (183)
3 (146)
4 (140)
5 (96)
8 (188)
9 (156)
10 (135)
11 (143)
12 (93)
15 (136)
16 (133)
17 (114)
18 (129)
19 (103)
22 (107)
23 (102)
29 (101)
30 (73)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
29
30
FDA
Meda AB Announces First Combination of NSAID and Proton Pump Inhibitor Approved
December 9, 2008
·
1 min read
Drug Development
Javelin Pharmaceuticals’s Dyloject Significantly Reduces Moderate-to-Severe Pain in Pivotal Phase 3 Orthopedic Surgical Trial
December 9, 2008
·
6 min read
Drug Development
US Oncology, Inc. New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia
December 9, 2008
·
4 min read
Drug Development
Omeros Corporation Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
December 9, 2008
·
2 min read
Drug Development
Cell Therapeutics, Inc. Release: Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin’s Lymphoma
December 9, 2008
·
6 min read
Drug Development
Apthera, Inc. Announces Phase III and Commercial Drug Formulation for NeuVax(TM)
December 9, 2008
·
1 min read
Business
Starpharma Holdings Ltd Full License Agreement Signed For VivaGel Coated Condoms
December 9, 2008
·
1 min read
Interface Biologics Secures $5M Financing and Appoints Thomas P. Reeves President and Chief Executive Officer
December 9, 2008
·
3 min read
Drug Development
Calistoga Pharmaceuticals Release: CAL-101, an Oral p110d Isoform-Selective PI3 Kinase Inhibitor, Demonstrates Preclinical Activity in Hematologic Cancer Cells
December 9, 2008
·
1 min read
Genetown
Candela Files Requests for Re-Examination of Palomar Hair Patents
December 9, 2008
·
1 min read
Previous
9 of 16
Next
